Drawing for HCP NETWORK

USPTO serial 85296550

HCP NETWORK

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LOVELACE, JAMES B
Law office
LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with HCP NETWORK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gwenn Roos

GWENN ROOS LAW OFFICE OF GWENN ROOS26 BROOKDALE AVEWELLESLEY, MA 02482-1021UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Advice in the field of business management; Business advisory services, consultancy and information; Business and management consulting for healthcare providers and related businesses; Business collaboration services, namely, providing a national computer-based networking web site for health care educators and medical educators to collaborate across disciplines to help improve health care education and medical education; Business consultation; Business consultation in the field of sales, training, medicine and pharmaceuticals; Business consultation services; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, providing information management services; Business consulting services in the field of sales, training, medicine and pharmaceuticals; Business management and consulting services for the health care industry, namely, customer service, accounting services, and marketing services; Business management and consulting services for the health care industry, namely, customer service, accounting services; Business management consulting with relation to strategy, sales, operation, product design particularly specializing in the use of analytic and statistic models for the understanding and predicting of consumers, businesses, and market trends and actions; Consultation services, namely, creative and strategic consultation regarding development for others; Consulting in sales techniques and sales programmes; Consulting in the field of sales methods, sales management, and sales improvement; Consulting in the fields of healthcare operations management and hospital operations management; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Information about sales methods; Management and business consulting services in the field of training and recruitment; Management and business consulting services in the field of sales, training, medicine and pharmaceuticals; Modeling for advertising or sales promotion; Modeling services for advertising or sales promotion; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals and life sciences; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Sales demonstrationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 1, 2012MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 1, 2012ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 22, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 9, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 9, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 3, 2012ALIEASSIGNED TO LIE—
Jan 23, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 15, 2011CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 15, 2011COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 21, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 21, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 21, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 21, 2011DOCKASSIGNED TO EXAMINER—
Apr 19, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 19, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance